skip to main content
Idioma:
Resultados 1 2 3 4 next page
Refinado por: Base de dados/Biblioteca: Journals@Ovid Ovid Full Text remover assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer
PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer

Zinner, Ralph G. ; Obasaju, Coleman K. ; Spigel, David R. ; Weaver, Robert W. ; Beck, J. Thaddeus ; Waterhouse, David M. ; Modiano, Manuel R. ; Hrinczenko, Borys ; Nikolinakos, Petros G. ; Liu, Jingyi ; Koustenis, Andrew G. ; Winfree, Katherine B. ; Melemed, Symantha A. ; Guba, Susan C. ; Ortuzar, Waldo I. ; Desaiah, Durisala ; Treat, Joseph A. ; Govindan, Ramaswamy ; Ross, Helen J.

Journal of thoracic oncology, 2015-01, Vol.10 (1), p.134-142 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non–Small-Cell Lung Cancer: NCCTG and SWOG Study N0426
Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non–Small-Cell Lung Cancer: NCCTG and SWOG Study N0426
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non–Small-Cell Lung Cancer: NCCTG and SWOG Study N0426

ADJEI, Alex A ; MANDREKAR, Sumithra J ; ZINNER, Ralph G ; DY, Grace K ; MOLINA, Julian R ; ADJEI, Araba A ; GANDARA, David R ; ALLEN ZIEGLER, Katie L ; STELLA, Philip J ; ROWLAND, Kendrith M ; SCHILD, Steven E

Journal of clinical oncology, 2010-02, Vol.28 (4), p.614-619 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
3
S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer
S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer

Shen, Hua ; Wang, Gao-Chan ; Li, Xiang ; Ge, Xin ; Wang, Meng ; Shi, Zhu-Mei ; Bhardwaj, Vikas ; Wang, Zi-Xuan ; Zinner, Ralph G ; Peiper, Stephen C ; Aplin, Andrew E ; Jiang, Bing-Hua ; He, Jun

Oncogene, 2020-12, Vol.39 (49), p.7181-7195 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine
RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine
Material Type:
Artigo 		Adicionar ao Meu Espaço

RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine

DUXBURY, Mark S ; ITO, Hiromichi ; ZINNER, Michael J ; ASHLEY, Stanley W ; WHANG, Edward E

Oncogene, 2004-02, Vol.23 (8), p.1539-1548 [Periódico revisado por pares]

Basingstoke: Nature Publishing

Texto completo disponível

Citações Citado por
5
EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma
EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma

DUXBURY, Mark S ; ITO, Hiromichi ; ZINNER, Michael J ; ASHLEY, Stanley W ; WHANG, Edward E

Oncogene, 2004-02, Vol.23 (7), p.1448-1456 [Periódico revisado por pares]

Basingstoke: Nature Publishing

Texto completo disponível

Citações Citado por
6
Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation
Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation

Fu, S. ; Hou, M.M. ; Naing, A. ; Janku, F. ; Hess, K. ; Zinner, R. ; Subbiah, V. ; Hong, D. ; Wheler, J. ; Piha-Paul, S. ; Tsimberidou, A. ; Karp, D. ; Araujo, D. ; Kee, B. ; Hwu, P. ; Wolff, R. ; Kurzrock, R. ; Meric-Bernstam, F.

Annals of oncology, 2015-05, Vol.26 (5), p.1012-1018 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Dose‐escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF‐mutated advanced cancers
Dose‐escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF‐mutated advanced cancers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dose‐escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF‐mutated advanced cancers

Janku, Filip ; Sakamuri, Divya ; Kato, Shumei ; Huang, Helen J. ; Call, S. Greg ; Naing, Aung ; Holley, Veronica R. ; Patel, Sapna P. ; Amaria, Rodabe N. ; Falchook, Gerald S. ; Piha‐Paul, Sarina A. ; Zinner, Ralph G. ; Tsimberidou, Apostolia M. ; Hong, David S. ; Meric‐Bernstam, Funda

Cancer, 2021-02, Vol.127 (3), p.391-402 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
8
CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells
CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells

DUXBURY, Mark S ; ITO, Hiromichi ; ZINNER, Michael J ; ASHLEY, Stanley W ; WHANG, Edward E

Oncogene, 2004-01, Vol.23 (2), p.465-473 [Periódico revisado por pares]

Basingstoke: Nature Publishing

Texto completo disponível

Citações Citado por
9
Description of a Lung Cancer Hotspot: Disparities in Lung Cancer Histology, Incidence, and Survival in Kentucky and Appalachian Kentucky
Description of a Lung Cancer Hotspot: Disparities in Lung Cancer Histology, Incidence, and Survival in Kentucky and Appalachian Kentucky
Material Type:
Artigo 		Adicionar ao Meu Espaço

Description of a Lung Cancer Hotspot: Disparities in Lung Cancer Histology, Incidence, and Survival in Kentucky and Appalachian Kentucky

Brainson, Christine F. ; Huang, Bin ; Chen, Quan ; McLouth, Laurie E. ; He, Chunyan ; Hao, Zhonglin ; Arnold, Susanne M. ; Zinner, Ralph G. ; Mullett, Timothy W. ; Bocklage, Therese J. ; Orren, David K. ; Villano, John L. ; Durbin, Eric B.

Clinical lung cancer, 2021-11, Vol.22 (6), p.e911-e920 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
10
Gene-Based Therapy: Novel Approaches
Gene-Based Therapy: Novel Approaches
Material Type:
Artigo 		Adicionar ao Meu Espaço

Gene-Based Therapy: Novel Approaches

Zinner, Ralph

Journal of thoracic oncology, 2009-11, Vol.4 (11), p.S1086-S1089 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2003  (4)
  2. 2003Até2005  (6)
  3. 2006Até2009  (6)
  4. 2010Até2014  (11)
  5. Após 2014  (14)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.